학술논문

SOF/VEL/VOX for 8 or 12 weeks is well tolerated and results in high SVR12 rates in patients receiving opioid substitution therapy
Document Type
Journal
Source
JOURNAL OF HEPATOLOGY; 2017, 66 1, pS513-pS514, 2p. Supplement: S
Subject
Language
English
ISSN
16000641